Roundtable on Black in cancer research and oncology - presented by Dr. Brandon Blue MD and Dr. Kilan Ashad-Bishop and Drs. Onyinye and Folu Balogun and Runcie C.W. Chidebe Dip., BSc., MSc., and Kathryn Mcginnis and Dr Paraskevi Mallini and Dr. Lisa Hoffmann-Haas

Roundtable on Black in cancer research and oncology

Brandon Blue, Kilan Ashad-Bishop, Onyinye and Folu Balogun and Runcie C.W. Chidebe

Dr. Brandon Blue MDDr. Kilan Ashad-BishopDrs. Onyinye and Folu BalogunRuncie C.W. Chidebe Dip., BSc., MSc.,
Slide at 19:01
Epidemiology of endometrial cancer Most common gynecologic malignancy in the United States The Onc Docs Dr. On. 9th most common overall, 4th most common among women Estimated New Cases in 2021 66,570 5-Year Relative Survival % of All New Cancer Cases 3.5% 81.1% Estimated Deaths in 2021 12,940 2011-2017 % of All Cancer Deaths 2.1% 1992 1996 2000 2004 2008 2012 2016 2019 Year Rate of New Cases Death Rate https://seer.cancer.gov Weill Cornell Medicine NewYork-Presbyterian
1
References
  • 1.
    https://seer.cancer.gov
Share slide
Summary (AI generated)

In low and middle-income countries, cervical cancer is not the most common type of cancer. However, recent statistics and discussions with my colleagues indicate that it is increasing in prevalence. Therefore, addressing this issue is crucial.

Initially, cervical cancer may seem to have a relatively high survival rate compared to other cancers, with a five-year survival rate of 81%. However, there is a concerning trend of rising incidents and mortality rates for endometrial cancer. This data is derived from the annual cancer report to the nation, which reveals that uterine cancer is not only increasing in incidents but also has the highest mortality rate among all cancers.